Cai, Z., Li, W., Hager, S., Wilson, J. L., Afjehi-Sadat, L., Heiss, E. H., Weichhart, T., Heffeter, P., & Weckwerth, W. (2024). Targeting PHGDH reverses the immunosuppressive phenotype of tumor-associated macrophages through α-ketoglutarate and mTORC1 signaling. Cellular and Molecular Immunology, 21(5), 448-465. https://doi.org/10.1038/s41423-024-01134-0

Louro, H., Vettorazzi, A., López de Cerain, A., Spyropoulou, A., Solhaug, A., Straumfors, A., Behr, A. C., Mertens, B., Žegura, B., Fæste, C. K., Ndiaye, D., Spilioti, E., Varga, E., Dubreil, E., Borsos, E., Crudo, F., Eriksen, G. S., Snapkow, I., Henri, J., ... Marko, D. (2024). Hazard characterization of Alternaria toxins to identify data gaps and improve risk assessment for human health. Archives of Toxicology, 98(2), 425-469. https://doi.org/10.1007/s00204-023-03636-8

Schaier, M., Falcone, E., Prstek, T., Vileno, B., Hager, S., Keppler, B. K., Heffeter, P., Koellensperger, G., Faller, P., & Kowol, C. R. (2023). Human serum albumin as a copper source for anticancer thiosemicarbazones. Metallomics, 15(8), [mfad046]. https://doi.org/10.1093/mtomcs/mfad046

Strasser, P., Montsch, B., Weiss, S., Sami, H., Kugler, C., Hager, S., Schueffl, H., Mader, R., Brüggemann, O., Kowol, C. R., Ogris, M., Heffeter, P., & Teasdale, I. (2023). Degradable Bottlebrush Polypeptides and the Impact of their Architecture on Cell Uptake, Pharmacokinetics, and Biodistribution In Vivo. Small, 19(22), [2300767]. https://doi.org/10.1002/smll.202300767